The drug is called Sovaldi.
It was approved for use by the FDA in December and has already become massively used.
Sovaldi was developed to treat hepatitis C and it does so with an amazing success.
The drug has cured close to 90% of the of those taking it, and has virtually no side effects.
So there’s no downside, right?
The answer is yes for everyone but insurance companies. CBS says Sovaldi costs an average of $1,000 per day with expectations of up to $10 billion in sales in 2014.
The Wall Street Journal reports insurers have done the math and see the drug causing a 10% hit to their bottom line.
While insurance companies are not likely to get much sympathy, there is another side to the equation.
Forbes points out many hepatitis C patients are uninsured, veterans, incarcerated, or on Medicaid.
That means the cost of the drug will end up hitting taxpayers in the wallet.
Congress has even gotten involved, asking the drug company that makes Sovaldi, Gilead, why the drug is so expensive.
They ask why the same drug costs, and this isn’t a misprint, 99% less in Egypt.
Gilead explains they price the drug using the per-capita income of a nation.